Page 14 - Pharmaceutical

Eisai and Novartis to co-promote anticancer drugs in US

Two companies will promote Eisai's anticancer agent Lenvima in combination with everolimus as treatment for advanced renal cell carcinoma in the US

Lupin receives US FDA's nod for antifungal drug voriconazole

The company has received approval for voriconazole tablet (50 mg & 200 mg) and oral suspension (40 mg/mL) - generic versions of PF Prism CV's Vfend tablet and oral suspension

Frontida BioPharm buys Sun Pharma's two US facilities

Sun Pharma has sold its two oral solid dosage manufacturing facilities located at Philadelphia and Aurora, along with 15 related products, to Frontida BioPharm

Dr Reddy's launches psoriasis drug Sernivo in US

Sernivo (betamethasone dipropionate) spray is used for the treatment of mild to moderate plaque psoriasis

Jubilant Biosys inks license pact with US-based Checkpoint for cancer drug

As per the deal, Jubilant Biosys will receive an upfront payment of $ 2 mn and contingent preclinical, clinical and regulatory payments including commercial milestones totalling up to $ 180 mn

Dr Reddy's acquires 6 OTC brands from Ducere Pharma in US

With this, the Hyderabad based pharma major has entered the branded consumer health market in the US

Ajanta Pharma receives US FDA approval of antifungal voriconazole tablet

Voriconazole is the generic version of Vfend, manufactured by PF Prism CV

Novartis to create two units to focus on pharma and oncology

The new structure reflects the importance of oncology to Novartis following the successful integration of the oncology assets acquired from GSK

Suven Life bags product patents for NCEs in Australia, Eurasia, Israel and US

The patents have been granted to the company's new chemical entities (NCEs) for CNS therapy through mechanism of action - H3 inverse agonist

Ajanta Pharma receives US FDA nod for migraine drug zolmitriptan

Zolmitriptan tablet is a generic version of Zomig, a registered trademark of AstraZeneca

India and Japan to seek regulatory collaboration for medical products

The Japan has extended support to Government of India for Indian regulators' skill enhancement through its Asia Training Centre

Pharma exports to witness a sharp fall as value of off-patent drugs declines

While the exports witnessed growth of 19 percent in the last decade, it is expected to decline sharply to 10-12 percent annually over the next 5 years, says a Crisil Research report

Strides Shasun to divest UK arm for Rs 240 crore

Shasun Pharma Solutions Ltd (SPSL), which is into CRAMS API business, will be bought by the current management team of SPSL

Strides Shasun's Australian arm inks supply pact with Pharmacy Alliance

The new agreement also includes investment by Arrow Pharmaceuticals, Strides Shasun's Australian subsidiary, in Pharmacy Alliance's plans for growth and retail innovation

Aurobindo Pharma receives US FDA nod for hydromorphone tablet

Hydromorphone hydrochloride tablet, used to relieve moderate to severe pain, has an estimated market size of $ 50 mn for the twelve months ending March 2016, according to IMS

Mylan acquires Renaissance's dermatology biz for $ 1 bn

With this acquisition, the company will have critical mass in the dermatology/topicals area and catapult to a leading position in this space, says Rajiv Malik, president, Mylan

Pfizer to buy biopharma firm Anacor for $ 5.2 bn

Anacor will be a strong fit with Pfizer's innovative business, further supporting its strategic focus on inflammation and immunology

AMRI buys Italian API maker Euticals for $ 358 mn

The deal positions AMRI as one of the largest independent developers and suppliers of API to the pharmaceutical industry